Breast cancer screening by clinical breast examination and a new instrument named iBreastExam
Phase 4
Completed
- Registration Number
- CTRI/2020/01/022727
- Lead Sponsor
- Prayas
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 10000
Inclusion Criteria
Consenting women
Exclusion Criteria
Women who have undergone breast surgery
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. The outcome will be women detected with breast cancer correctly by clinical breast examination and iBreastExam <br/ ><br> <br/ ><br>2. Test performance of clinical breast exam and iBreastExam in detecting breast cancerTimepoint: single
- Secondary Outcome Measures
Name Time Method To study the test performance of CBE and iBreastExam in detecting lumps with histopathology as the reference standard <br/ ><br>Timepoint: cross-sectional